ICY:FRA
Incyte Corp
€98,58
arrow_downward
-0,94%(-0,94) 1D
8 ຕ.ລ., 16 ໂມງ 45 ນາທີ 12 ວິນາທີ GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ICY...
Open
€100,50
High
€100,50
Low
€98,16
Mkt. cap
22,54 ຕື້
Avg. vol.
31,00
Volume
82,00
52-wk high
€115,40
52-wk low
€72,28
No. of employees
3 ພັນ
Open
€100,50
High
€100,50
Low
€98,16
Mkt. cap
22,54 ຕື້
Avg. vol.
31,00
Volume
82,00
52-wk high
€115,40
52-wk low
€72,28
No. of employees
3 ພັນ
News stories
From web sources and news partners
Business Wire
·
3 ຊົ່ວໂມງກ່ອນ
Incyte to Report Third Quarter Financial Results
Benzinga
·
17 ຊົ່ວໂມງກ່ອນ
If You Invested $1000 In Incyte Stock 15 Years Ago, You Would Have This Much Today
AD HOC NEWS
·
1 ມື້ກ່ອນ
Stifel raises target for Incyte stock to USD 157
MarketWatch
·
1 ມື້ກ່ອນ
Incyte Corp. stock underperforms Tuesday when compared to competitors
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2,84 ພັນ
Founded2002
HeadquartersWilmington, ເດລາແວ, ສະຫະລັດ
SectorBiotechnology
Websiteincyte.com